International Biotechnology Trust PLC Biocryst Pharmaceuticals Inc Transaction History

International Biotechnology Trust PLC

  • $295 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$10.79 - $14.81 $608,534 - $835,254
56,398 Added 9368.44%
57,000 $718,000
Q2 2022

Aug 16, 2022
SELL
$7.89 - $17.88 $444,980 - $1.01 Million
-56,398 Reduced 98.94%
602 $57 Million
Q1 2022

May 20, 2022
BUY
$11.56 - $19.76 $658,920 - $1.13 Million
57,000 New
57,000 $926,000

Others Institutions Holding BCRX

# of Institutions
278
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email